For commercial members enrolled in an IBC prescription drug program, prior
authorization and quantity limit requirements will be applied to certain drugs.
The purpose of prior authorization is to ensure that drugs are medically 
necessary
and are being used appropriately. Quantity limits are designed to allow a 
sufficient
supply of medication based upon the maximum daily dose and length of therapy
approved by the U.S. Food and Drug Administration for a particular drug. The
most recent updates are reflected below.
Drugs requiring prior authorization
The prior authorization requirement for the following non-formulary drugs 
was effective at the time the drugs became
available in the marketplace:
Brand drug
	Generic drug
		Drug category
			Effective date
Farxiga?
	Not available
		Diabetes, Thyroid, Steroids, & Other Miscellaneous Hormones
			January 27, 2014
Imbruvica?
	Not available
		Cancer & Organ Transplant Drugs
			November 18, 2013
Olysio?
	Not available
		Antibiotics & Other Drugs Used for Infection
			December 2, 2013
Otrexup?
	Not available
		Bone, Joint, & Muscle
			December 30, 2013
Sovaldi? 
	Not available 
		Antibiotics & Other Drugs Used for Infection
			December 16, 2013
Stendra?  
	Not available
		 Urinary & Prostate Meds
			January 13, 2014
			
The following drugs have been added to the list of drugs requiring prior 
authorization:
			
Brand drug
	Generic drug
		Drug category
			Effective date
Adasuave
®
	 Not available
		Pain, Nervous System, & Psych
			July 1, 2014
Advair
®
	Not available
		Allergy, Cough & Cold, Lung Meds
			July 1, 2014
Aerospan?
	Not available
		Allergy, Cough & Cold, Lung Meds
			July 1, 2014
Alvesco
®
	Not available
		Allergy, Cough & Cold, Lung Meds
			July 1, 2014
Exalgo?
	Not available
		Pain, Nervous System, & Psych
			July 1, 2014
Fetzima?
	Not available
		Pain, Nervous System, & Psych
			July 1, 2014
Flovent
®
	Not available
		Allergy, Cough & Cold, Lung Meds
			July 1, 2014
Pulmicort Flexhaler
®
	Not available
		Allergy, Cough & Cold, Lung Meds
			July 1, 2014
			
Drugs with quantity limits
			Quantity limits will be added for the following drugs:
			
Brand drug
	Generic drug
		Quantity limit
			Effective date
Aciphex
®
	rabeprazole* 
		30 tabs per 30 days
			November 18, 2013
Focalin? XR
	dexmethylphenidate hcl*
		30 tabs per 30 days
			November 25, 2013
Stendra?
	Not available 
		8 tabs per 30 days
			January 13, 2014
Zomig
®  Spray 2.5 mg
	Not available 
		9 bottles per 30 days
			July 1, 2014
			
*Quantity limits currently exist for brand drugs and will 
apply to generics at the dates indicated above.
			
			Drug no longer requiring prior authorization
			Prior authorization was removed for the following drug:
			
Brand drug
	Generic drug
		Formulary chapter
			Effective date
Tecfidera
®
	 Not available  
		Pain, Nervous System, & Psych
			May 1, 2014
			
For additional information on pharmacy policies and programs, please visit 
our Pharmacy 
Information web page.